National Taiwan University Medical Center
Taipei, 7, Chung-Shan S. Road, 100, Taiwan
NCT Number: NCT00155675
The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.
Looking for future studies?
Notify Me45 year–70 year
Female
Interventional
Phase 1
Taipei, 7, Chung-Shan S. Road, 100, Taiwan
Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postmenpausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal woman with established osteoporosis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeNational Taiwan University Hospital
Other
Clinical Effect of Traditional Chinese Medicine - "Gusuibu"
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07187518
Back Injuries, Bone Diseases
Berlin, Germany
View Trial DetailsNCT03926377
Autoimmune Diseases, Bone Diseases
Amiens, France
View Trial DetailsNCT02533713
Bone Diseases, Bone Diseases, Metabolic
Englewood, Colorado, United States
View Trial DetailsNCT04565743
Bone Diseases, Bone Diseases, Metabolic
Huddinge, Stockholm County, Sweden
View Trial Details